Tools
ToolsHenry, N L, Pchejetski, D, A'Hern, R, Nguyen, A T, Charles, P, Waxman, J, Li, L, Storniolo, A M, Hayes, D F, Flockhart, D A, Stearns, V and Stebbing, J (2010) Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. British Journal of Cancer, 103 (3). pp. 291-296. ISSN 0007-0920
Full text not available from this repository. (Request a copy)Abstract
The aromatase inhibitor (AI)-associated musculoskeletal syndrome (AIMSS) occurs in approximately 50% of AI-treated patients. Inflammatory mediators are associated with oestrogen signalling and may change with oestrogen depletion. We hypothesised that AIMSS may be associated with changes in circulating inflammatory markers.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | aged,androstadienes,antineoplastic agents,aromatase inhibitors,breast neoplasms,bridged compounds,case-control studies,cytokines,estrogens,female,humans,inflammation,middle aged,musculoskeletal diseases,postmenopause,syndrome,tamoxifen,taxoids |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| Depositing User: | Pure Connector |
| Date Deposited: | 16 Dec 2014 10:06 |
| Last Modified: | 21 Oct 2022 00:22 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/51536 |
| DOI: | 10.1038/sj.bjc.6605768 |
Actions (login required)
 |
View Item |